News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
171 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
1 (184)
2 (144)
5 (162)
6 (107)
7 (309)
8 (243)
9 (171)
12 (212)
13 (134)
14 (258)
15 (267)
16 (110)
19 (118)
20 (147)
21 (149)
22 (140)
23 (133)
26 (20)
27 (148)
28 (183)
29 (192)
30 (107)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
31
Special edition
Deep Dive: Biopharma In Turmoil As Peter Marks Forced Out of FDA
Peter Marks, the venerable head of the FDA’s Center for Biologics Evaluation and Research, has been forced out. In this special edition of BioPharm Executive,
BioSpace
takes a deep dive into the instability of the HHS.
May 9, 2025
·
2 min read
·
Annalee Armstrong
Regulatory
FDA Delays Continue as Regulator Misses Review Date for GSK’s Nucala
The missed PDUFA adds to a string of delays at the FDA in recent weeks, including at least two other missed target action dates.
May 9, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Amid Layoffs, Delays, FDA Turns to AI for Speedy Reviews
The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the rollout immediately.
May 9, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review of potential strategic alternatives and options for the business.
May 9, 2025
·
2 min read
·
Tristan Manalac
Editorial
Rest Up, Biopharma. Trump’s Drug Pricing Policy Is Coming on Monday
With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have railed against, the industry’s tumultuous ride is far from over.
May 9, 2025
·
4 min read
·
Annalee Armstrong
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
The company discontinued development last month of its most mature asset, RLYB212, following disappointing mid-stage pharmacokinetic findings in a rare bleeding disorder.
May 9, 2025
·
2 min read
·
Tristan Manalac
Editorial
Doubts About Job Market Turning Around Soon Easy To Understand
In a recent
BioSpace
LinkedIn poll, nearly half of respondents predicted the job market won’t turn around until 2027 or later. It’s easy to see why people are skeptical, especially when you consider recent hiring activity and layoffs.
May 9, 2025
·
3 min read
·
Angela Gabriel
Layoffs
Insitro Cuts 22% of Workforce, Extending Runway Into 2027
Insitro’s layoffs affect about 65 employees as the AI-focused biotech looks to advance its pipeline in metabolic disease and neuroscience.
May 9, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Kriya Presents Data at the 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
May 9, 2025
·
4 min read
Press Releases
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
May 9, 2025
·
1 min read
1 of 18
Next